Hannah C. Moore

Understanding parental decisions to decline or delay infant RSV immunisation, nirsevimab, in Western Australia in 2024.

Maternal influenza vaccine reduces the risk of RSV and related respiratory hospitalisations in early infancy: an epidemiological study.

Prospective longitudinal study of respiratory syncytial virus and other respiratory viruses in children <5 years in community settings in metropolitan western Australia: the PATROL study.

Country-level and global burden of diseases caused by group A <i>Streptococcus:</i> protocol for a multicountry epidemiological study.

Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia

Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024.

Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants

Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)-associated hospitalisations, Western Australia, 2024: a population-based analysis.

Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants.

Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis.

Estimating the impact of Western Australia's first respiratory syncytial virus immunisation program for all infants: A mathematical modelling study.

Determinants of respiratory syncytial virus and human metapneumovirus transmission.

The Unintended Impact of COVID-19 Associated Non-Pharmaceutical Interventions on Paediatric Hospital Admissions: An Interrupted Time Series Analysis.

Who is at risk of a respiratory syncytial virus hospitalisation? A linked, population-based birth cohort analysis in children aged less than 5 years.

Neonatal and infant mortality after maternal influenza and pertussis vaccination: Probabilistically linked cohort study.

Socio-economic inequality underpins inequity in influenza vaccination uptake between public and private secondary schools: an Australian population-based study.

Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children.

Validity of using a semi-automated screening tool in a systematic review assessing non-specific effects of respiratory vaccines.

"We've wanted to vaccinate against it and now we can": views of respiratory syncytial virus disease and immunisation held by caregivers of Aboriginal children in Perth, Western Australia.

Spatiotemporal patterns of influenza in Western Australia.

Predicting regional and temporal incidence of RSV and influenza hospitalizations in a birth cohort of young Australian children.

Impact of vaccine mandates and removals on COVID-19 vaccine uptake in Australia and international comparators: a study protocol.

Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool.

The Changing Detection Rate of Respiratory Syncytial Virus in Adults in Western Australia between 2017 and 2023.

Parental awareness and attitudes towards prevention of respiratory syncytial virus in infants and young children in Australia.

Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care.

Impact of early childhood infection on child development and school performance: a population-based study

Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study.

Respiratory Viral Testing Rate Patterns in Young Children Attending Tertiary Care Across Western Australia: A Population-Based Birth Cohort Study.

Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants.